Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Idiopathic pulmonary fibrosis in adults: diagnosis and management

Clinical guideline
Reference number: CG163
Published: 12 June 2013
Last updated: 23 May 2017

History

Surveillance consultation

Surveillance consultation
Comments form (MSWord 28 KB)

Published:

09 December 2016
Surveillance review proposal (PDF 485 KB)

Published:

09 December 2016

Stakeholder list updated

Stakeholder list (PDF 42 KB)

Published:

07 December 2016

Background information

Press release information

Equality impact assessment

Equality impact assessment (PDF 104 KB)

Published:

12 June 2013

Stakeholder comments table

Stakeholder comments table (PDF 830 KB)

Published:

12 June 2013

Guideline development and consultation

Guideline development and consultation
Guideline consultation information
Full version (PDF 3.23 MB)

Published:

11 January 2013
Appendices (PDF 8.51 MB)

Published:

11 January 2013
NICE guideline (PDF 202 KB)

Published:

08 January 2013
Stakeholder list (PDF 136 KB)

Published:

16 May 2012
Economic plan (PDF 12 KB)

Published:

20 November 2012
Review questions (PDF 254 KB)

Published:

20 November 2012
Health economic search strategies (PDF 713 KB)

Published:

20 November 2012
GDG minutes
GDG minutes 12 (PDF 78 KB)

Published:

19 December 2012
GDG minutes 9 (PDF 90 KB)

Published:

19 December 2012
GDG minutes 11 (PDF 107 KB)

Published:

29 November 2012
GDG minutes 10 (PDF 94 KB)

Published:

12 October 2012
GDG minutes 8 (PDF 128 KB)

Published:

09 August 2012
GDG minutes 7 (PDF 91 KB)

Published:

26 July 2012
Idiopathic pulmonary fibrosis GDG minutes 6 (PDF 85 KB)

Published:

23 May 2012
Idiopathic pulmonary fibrosis GDG minutes 5 (PDF 90 KB)

Published:

01 May 2012
Idiopathic pulmonary fibrosis GDG minutes 4 (PDF 68 KB)

Published:

13 March 2012
Idiopathic pulmonary fibrosis GDG minutes 3 (PDF 188 KB)

Published:

16 February 2012
Idiopathic pulmonary fibrosis GDG minutes 2 (PDF 69 KB)

Published:

28 December 2011
Idiopathic pulmonary fibrosis GDG minutes 1 (PDF 65 KB)

Published:

28 December 2011
Guideline development group membership (PDF 11 KB)

Published:

31 July 2012

Scoping workshop, consultation and final scope

Scoping workshop, consultation and final scope
Final scope (PDF 54 KB)

Published:

04 August 2011
Equality impact assessment (PDF 135 KB)

Published:

04 August 2011
Consultation comments table (PDF 133 KB)

Published:

04 August 2011
Scope consultation information
Draft scope (PDF 65 KB)

Published:

28 January 2011
Comments proforma (MSWord 44 KB)

Published:

28 January 2011
Idiopathic pulmonary fibrosis stakeholder workshop notes: 16 December 2010 (PDF 92 KB)

Published:

07 June 2011

Remit

Remit (PDF 7 KB)

Published:

26 March 2010